A detailed history of Jgp Global Gestao De Recursos Ltda. transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Jgp Global Gestao De Recursos Ltda. holds 12,950 shares of KOD stock, worth $49,210. This represents 0.06% of its overall portfolio holdings.

Number of Shares
12,950
Previous 14,957 13.42%
Holding current value
$49,210
Previous $35,000 5.71%
% of portfolio
0.06%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$2.2 - $3.25 $4,415 - $6,522
-2,007 Reduced 13.42%
12,950 $33,000
Q1 2024

May 08, 2024

SELL
$3.01 - $7.45 $367 - $908
-122 Reduced 0.81%
14,957 $78,000
Q4 2023

Jan 19, 2024

BUY
$1.4 - $3.24 $21,110 - $48,855
15,079 New
15,079 $45,000
Q1 2022

May 05, 2022

SELL
$7.09 - $89.45 $46,262 - $583,661
-6,525 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$80.85 - $128.49 $161 - $256
-2 Reduced 0.03%
6,525 $553,000
Q3 2021

Nov 04, 2021

BUY
$81.97 - $106.94 $80,740 - $105,335
985 Added 17.77%
6,527 $626,000
Q2 2021

Aug 09, 2021

BUY
$77.2 - $126.54 $231 - $379
3 Added 0.05%
5,542 $515,000
Q1 2021

May 11, 2021

BUY
$110.45 - $164.47 $146,456 - $218,087
1,326 Added 31.47%
5,539 $628,000
Q4 2020

Jan 27, 2021

BUY
$60.78 - $154.03 $13,918 - $35,272
229 Added 5.75%
4,213 $619,000
Q3 2020

Nov 12, 2020

BUY
$45.05 - $59.27 $4,324 - $5,689
96 Added 2.47%
3,984 $236,000
Q2 2020

Aug 10, 2020

BUY
$42.74 - $66.25 $166,173 - $257,580
3,888 New
3,888 $210,000
Q1 2020

May 07, 2020

SELL
$38.18 - $73.95 $148,443 - $287,517
-3,888 Closed
0 $0
Q4 2019

Jan 24, 2020

BUY
$13.9 - $76.65 $54,043 - $298,015
3,888 New
3,888 $280,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $198M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Jgp Global Gestao De Recursos Ltda. Portfolio

Follow Jgp Global Gestao De Recursos Ltda. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jgp Global Gestao De Recursos Ltda., based on Form 13F filings with the SEC.

News

Stay updated on Jgp Global Gestao De Recursos Ltda. with notifications on news.